Search
for
Sort by
Research 271–300 of 1000+
- Thiol/disulfide homeostasis in patients with telogen effluvium: is oxidative stress important in the pathogenesis of telogen effluvium?
- Vitiligo—Current Treatment Options and Future Perspectives
- Poster Presentations
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- Alopecia areata: medical treatments
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Skin Manifestations of Rheumatological Diseases
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- Skin manifestations associated with systemic diseases – Part I
- Research on the balance of thiol-disulfide in blood serum in women with telogen effluvium
- Psychiatric morbidity in children and adolescents with dermatological disorders
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome
- Improved anaphylaxis referral rates to specialized services from an Emergency Department
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Oral isotretinoin for acne
- Alopecia Areata: Treatment of Today and Tomorrow
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Nonhuman primate dermatology: a literature review
- Dermatologists’ perceptions on the utility and limitations of teledermatology after examining 55,000 lesions
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Off-label uses of retinoids in dermatology
- Rare and common manifestations of COVID‐19 in children